Amoxicillin is a favorable choice for outpatient use in pediatric patients given its relatively narrow spectrum of activity and palatable formulation.
Amanda Zahn McPherson, PharmD
Advertisement
PharmD, professor of pediatrics at the University of Georgia College of Pharmacy
Articles by Amanda Zahn McPherson, PharmD
Recent FDA approval of nirsevimab and clesrovimab have transformed RSV prevention in infants, prompting new recommendations from the CDC and AAP and replacing the long-standing role of palivizumab.
Advertisement
Latest Updated Articles
Evolving Strategies for RSV Prevention in InfantsPublished: September 29th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Semaglutide Shows Direct Organ-Protective Benefits Beyond Weight Loss in HFpEF
2
November 2025 Pharmacy Policy Updates
3
Recapping TMS 2025: Evolving Insights and Future Directions in Menopause Care
4
Immune Synergy May Explain Why Some Patients Achieve Durable Remission With Cilta-Cel
5
